Self-retaining gastrointestinal delivery device

• US 5,198,229 A
• Filed: 06/05/1991
• Issued: 03/30/1993
• Est. Priority Date: 06/05/1991
• Status: Expired due to Term

• Current Assignee: ALZA Corporation (Johnson & Johnson)
• Original Assignee: ALZA Corporation (Johnson & Johnson)
• Inventors: Theeuwes, Felix, Wong, Patrick S. L., Larsen, Steven D.
• Primary Examiner(s): Page, Thurman K.
• Assistant Examiner(s): BROUILLETTE, D GABRIELLE
• Application Number:
  US07/710,607
• Time in Patent Office: 664 Days
• Field of Search: 424/473, 424/438, 424/451, 424/422
• US Class Current: 424/473
• CPC Class Codes: A61K 9/0004 Osmotic delivery systems; Sustained release driven by osmosis, thermal energy or gas
• CPC Class Codes: A61K 9/0065 Forms with gastric retention, e.g. floating on gastric juice, adhering to gastric mucosa, expanding to prevent passage through the pylorus

Abstract

The present invention is directed to a fluid-imbibing drug delivery device having a first, low density such that it floats in the stomach contents for a predetermined prolonged period of time, during which prolonged period of time it dispenses a drug or other active agent to the stomach, and having a second, higher density such that the device exits the stomach at the end of the predetermined prolonged period of time.

Claims

1. A fluid-imbibing delivery device for dispensing an active agent to the stomach environment over a predetermined prolonged period of time of from several hours to months, wherein the device has a first, low density relative to the stomach environment of from about 0.5 to about 0.7 such that it floats in the stomach contents for the predetermined prolonged period of time, during which prolonged period of time it dispenses the active agent to the stomach, and has a second, higher density of from about 1.2 to about 1.4 such that the device sinks in and exits the stomach at the end of the predetermined prolonged period of time, the device comprising:

(a) a housing comprising at least a first wall section and a second wall section, the first and second wall sections being in reversibly sliding telescoping arrangement with each other, the first wall section having an open end adapted to fit within the second wall section, which housing maintains its integrity in the stomach environment;

(b) an active agent delivery chamber within the housing comprising

(i) at least one active agent formulation,

(ii) a first expansion means comprising an osmopolymer, an osmagent, or a mixture of an osmopolymer and an osmagent, and

(iii) an exit means;

(c) a bouyancy chamber within the housing, the bouyancy chamber having an open end defined by the open end of the first wall section; and

(d) an expansion chamber within the housing for separating apart the first and second wall sections after the predetermined prolonged period of time, the expansion chamber comprising

(i) a second expansion means comprising an osmopolymer, an osmagent, or a mixture of an osmopolymer and an osmagent, and

(ii) a push plate adjacent the open end of the first wall section.

2. A delivery device according to claim 1 which further comprises a partition layer between the active agent formulation and the first expansion means.

3. A delivery device according to claim 1 wherein the first wall section and the second wall section is each comprised of a semipermeable composition, and the device further comprises an impermeable wall within the bouyancy chamber and adjacent the walls of the first wall section.

4. A method for delivering an active agent to the stomach environment for a predetermined prolong period of from several hours to months, the method comprising:

(1) placing a delivery device into the stomach environment, where it floats in the stomach fluids as a result of a first, low density relative to the stomach environment of from about 0.5 to about 0.7, where the delivery device comprises;

(a) a housing comprising at least a first wall section and a second wall section, the first and second wall sections being in reversibly sliding telescoping arrangement with each other, the first wall section having an open end adapted to fit within the second wall section, which housing maintains its integrity in the stomach environment;

(b) an active agent delivery chamber within the housing comprising

(i) at least one active agent formulation,

(ii) a first expansion means comprising an osmopolymer, an osmagent, or a mixture of an osmopolymer and an osmagent, and

(iii) an exit means;

(c) a bouyancy chamber within the housing, the bouyancy chamber having an open end defined by the open end of the first wall section; and

(d) an expansion chamber within the housing for separating apart the first and second wall sections after the predetermined prolonged period of time, the expansion chamber comprising

(i) a second expansion means comprising an osmopolymer, an osmagent, or a mixture of an osmopolymer and an osmagent, and

(ii) a push plate adjacent the open end of the first wall section;

(2) allowing fluid to be imbibed through at least a portion of the housing of the delivery device for causing the first expansion means to expand to deliver agent formulation into the stomach environment for the predetermined prolonged period of time and for causing the second expansion means to expand to exert pressure on the slidably connected first and second wall sections to push apart and separate the two wall sections after the predetermined prolonged period of time, whereby the density of the device rises to from about 1.2 to about 1.4, causing the device to sink and exit the stomach.

5. A method according to claim 4 wherein the delivery device further comprises a partition layer between the active agent formulation and the first expansion means.

6. A method according to claim 4 wherein the first wall section and the second wall section is each comprised of a semipermeable composition, and the device further comprises an impermeable wall within the bouyancy chamber and adjacent the walls of the first wall section.